Roberto Brugnoli

2.3k total citations
51 papers, 991 citations indexed

About

Roberto Brugnoli is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Roberto Brugnoli has authored 51 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Psychiatry and Mental health, 17 papers in Clinical Psychology and 14 papers in Pharmacology. Recurrent topics in Roberto Brugnoli's work include Schizophrenia research and treatment (16 papers), Bipolar Disorder and Treatment (13 papers) and Treatment of Major Depression (13 papers). Roberto Brugnoli is often cited by papers focused on Schizophrenia research and treatment (16 papers), Bipolar Disorder and Treatment (13 papers) and Treatment of Major Depression (13 papers). Roberto Brugnoli collaborates with scholars based in Italy, United Kingdom and United States. Roberto Brugnoli's co-authors include Paolo Girardi, Georgios D. Kotzalidis, Gabriele Sani, Josep María Haro, Diego Novick, Antonio Del Casale, Chiara Rapinesi, Stefano Ferracuti, William Montgomery and Xiaomei Peng and has published in prestigious journals such as Journal of Affective Disorders, The Journal of Nervous and Mental Disease and Schizophrenia Research.

In The Last Decade

Roberto Brugnoli

50 papers receiving 973 citations

Peers

Countries citing papers authored by Roberto Brugnoli

Since Specialization

Citations

This map shows the geographic impact of Roberto Brugnoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Brugnoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Brugnoli more than expected).

Fields of papers citing papers by Roberto Brugnoli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Brugnoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Brugnoli. The network helps show where Roberto Brugnoli may publish in the future.

Co-authorship network of co-authors of Roberto Brugnoli

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Brugnoli. A scholar is included among the top collaborators of Roberto Brugnoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Brugnoli. Roberto Brugnoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Preliminary Report on the Effects of Daridorexant in Patients with Comorbid Insomnia and Substance Use Disorders 2025 ·Pharmaceuticals ·Marco Di Nicola, Maria Pepe, Lorenzo Bonomo, (unknown), Isabella Panaccione, Roberto Brugnoli, Gabriele Sani	1
2	A multivariate approach to investigate the associations of electrophysiological indices with schizophrenia clinical and functional outcome 2023 ·European Psychiatry ·Luigi Giuliani, Nikolaos Koutsouleris, Giulia Maria Giordano, Thomas Koenig, Armida Mucci, Andrea Perrottelli, (unknown), Mario Altamura, Antonello Bellomo, Roberto Brugnoli, Giulio Corrivetti, Giorgio Di Lorenzo, Paolo Girardi, Palmiero Monteleone, Cinzia Niolu, Silvana Galderisi, Mario Maj	6
3	Economic Impact of Schizophrenia from a Hospital and Social Security System Perspective in Italy 2021 ·Clinical Drug Investigation ·Francesco Saverio Mennini, Andrea Marcellusi, (unknown), (unknown), Paolo Sciattella, (unknown), (unknown), Mario Amore, Roberto Brugnoli	4
4	Expert Opinions and Consensus Recommendations for the Evaluation and Management of Insomnia in Clinical Practice: Joint Statements of Five Italian Scientific Societies 2020 ·Frontiers in Psychiatry ·Laura Palagini, Raffaele Manni, Eugenio Aguglia, Mario Amore, Roberto Brugnoli, Paolo Girardi, Luigi Grassi, Claudio Mencacci, Giuseppe Plazzi, (unknown), Lino Nobili, Giovanni Biggio	41
5	Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review 2019 ·Clinical Drug Investigation ·Chiara Rapinesi, Georgios D. Kotzalidis, Lorenzo Mazzarini, Roberto Brugnoli, Stefano Ferracuti, Sergio De Filippis, Ilaria Cuomo, Gloria Giordano, Antonio Del Casale, Gloria Angeletti, Gabriele Sani, Paolo Girardi	9
6	Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs) 2016 ·Rivista di psichiatria ·Roberto Brugnoli, Chiara Rapinesi, Georgios D. Kotzalidis, Andrea Marcellusi, Francesco Saverio Mennini, Sergio De Filippis, (unknown), Andrea Ballerini, (unknown), Giuseppe Ducci, Antonio Del Casale, Paolo Girardi	12
7	Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia 2016 ·Neuropsychiatric Disease and Treatment ·Diego Novick, William Montgomery, Josep María Haro, María Victoria Moneta, Gang Zhu, Yue Li, Jihyung Hong, Héctor Dueñas, Roberto Brugnoli	3
8	Add-on deep Transcranial Magnetic Stimulation (dTMS) for the treatment of chronic migraine: A preliminary study 2016 ·Neuroscience Letters ·Chiara Rapinesi, Antonio Del Casale, (unknown), Georgios D. Kotzalidis, Simone Di Pietro, Vittoria Rachele Ferri, Francesco Saverio Bersani, Roberto Brugnoli, Ruggero Raccah, Abraham Zangen, Stefano Ferracuti, Francesco Orzi, Paolo Girardi, Giuliano Sette	27
9	Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists 2015 ·Expert Opinion on Pharmacotherapy ·Andrea Fagiolini, Roberto Brugnoli, Guido Di Sciascio, Sergio De Filippis, Giuseppe Maina	17
10	Italian psychiatrists’ perception on cognitive symptoms in major depressive disorder 2015 ·International Journal of Psychiatry in Clinical Practice ·Umberto Albert, Roberto Brugnoli, Filippo Caraci, Bernardo Dell’Osso, Guido Di Sciascio, Alfonso Tortorella, (unknown), (unknown), Valeria Pegoraro	10
11	Which somatic symptoms are associated with an unfavorable course in Chinese patients with major depressive disorder? 2015 ·Asia-Pacific Psychiatry ·Diego Novick, William Montgomery, Jaume Aguado, Xiaomei Peng, Roberto Brugnoli, Josep María Haro	19
12	Alexithymia and self-reflectiveness in bronchial asthma 2015 ·Rivista di psichiatria ·Marco Innamorati, Alfredo Chetta, (unknown), (unknown), Marina Aiello, (unknown), (unknown), Martino Belvederi Murri, Roberto Brugnoli, Roberta Pisi, Maurizio Pompili, Mario Amore	4
13	Is nocturnal eating in restless legs syndrome linked to a specific psychopathological profile? A pilot study 2015 ·Journal of Neural Transmission ·(unknown), (unknown), Giovanni Rizzo, Elena Antelmi, Marco Innamorati, Maurizio Pompili, Roberto Brugnoli, Martino Belvederi Murri, Mario Amore, Federica Provini	7
14	Mitochondrial myopathy and comorbid major depressive disorder: effectiveness of dTMS on gait and mood symptoms 2015 ·General Hospital Psychiatry ·Chiara Rapinesi, Delfina Janiri, Georgios D. Kotzalidis, Daniele Serata, Antonio Del Casale, (unknown), (unknown), Giovanna Gentile, Giovanni Manfredi, (unknown), Ruggero Raccah, Roberto Brugnoli, (unknown), Vittoria Rachele Ferri, Stefano Ferracuti, Abraham Zangen, Maurizio Simmaco, Gloria Angeletti, Paolo Girardi	5
15	Antidepressant medication treatment patterns in Asian patients with major depressive disorder 2015 ·Patient Preference and Adherence ·Josep María Haro, Diego Novick, William Montgomery, (unknown), Xiaomei Peng, Roberto Brugnoli	15
16	Effectiveness of Short-Term Olanzapine in Patients With Bipolar I Disorder, With or Without Comorbidity With Substance Use Disorder 2013 ·Journal of Clinical Psychopharmacology ·Gabriele Sani, Georgios D. Kotzalidis, Paul A. Vöhringer, Daniela Pucci, Alessio Simonetti, Giovanni Manfredi, Valeria Savoja, Stefano Maria Tamorri, Lorenzo Mazzarini, Isabella Pacchiarotti, Carla Ludovica Telesforo, Stefano Ferracuti, Roberto Brugnoli, Elisa Ambrosi, Matteo Caloro, Antonio Del Casale, Alexia E. Koukopoulos, Derick Vergne, Paolo Girardi, S. Nassir Ghaemi	25
17	Which somatic symptoms are associated with an unfavorable course in Asian patients with major depressive disorder? 2013 ·Journal of Affective Disorders ·Diego Novick, William Montgomery, Jaume Aguado, Zbigniew Kadziola, Xiaomei Peng, Roberto Brugnoli, Josep María Haro	71
18	Antipsychotic Monotherapy and Polypharmacy in the Treatment of Outpatients With Schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study 2012 ·The Journal of Nervous and Mental Disease ·Diego Novick, Haya Ascher‐Svanum, Roberto Brugnoli, Jordan Bertsch, Jihyung Hong, Josep María Haro	9
19	Cinematic clinical psychiatric cases in graduate medical education 2004 ·Medical Education ·Lorenzo Tarsitani, Roberto Brugnoli, P. Pancheri	12
20	Single‐voxel long TE 1H‐MR spectroscopy of the normal brainstem and cerebellum 2002 ·Journal of Magnetic Resonance Imaging ·Mario Mascalchi, Roberto Brugnoli, Laura Guerrini, Giacomo Belli, (unknown), Letterio S. Politi, Cinzia Gavazzi, Francesco Lolli, Giovanni Argenti, Natale Villari	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact